Spectacular #RAKNYE 2022 Fireworks Show Sets Two GUINNESS WORLD RECORDS™ Titles, Mesmerising Thousands of Visitors
1.1.2022 14:06:00 EET | Business Wire | Press release
Welcoming hundreds of thousands of spectators from around the world, the Ras Al Khaimah New Year’s Eve Celebrations (#RAKNYE 2022) dazzled all with a never-before-seen fireworks display that smashed two GUINNESS WORLD RECORDS™ titles.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211231005082/en/
#RAKNYE 2022 Two GUINNESS WORLD RECORDS™ titles (Photo: AETOSWire)
Rising majestically from the Arabian Gulf, the fireworks display featured innovative pyrotechnic performances spanning an area of over 4.7 kilometres. The 12-minute spectacle was specially choreographed to reflect the joy of reunion with six themes set to epic orchestral music.
A spokesperson of the organising committee said: “#RAKNYE2022 is our tribute to the leadership and people of Ras Al Khaimah and the UAE not only as we celebrate the 50th Anniversary of our nation but also in preparation for the Next 50 Years. With this event, we once again underlined the reputation of Ras Al Khaimah as the leading tourism destination welcoming visitors from across the world.”
#RAKNYE 2020 fireworks display was conducted in a six-act sequence starting with the countdown just before midnight. Ushering in the New Year with a spectacular tower of lights, 1,055.8 metres high, the next act was a ‘Happy New Year’ message written in the sky with firework drones. This was followed by a tribute to the UAE backed by orchestral music, celebrating the achievements of the nation and its people. It segued to the next act when hundreds of drones displayed the UAE’s 50th Anniversary logo. The finale was in two parts – a multi-colour display of lights and a super-massive expanse of white that illuminated the skyline.
Setting the first GUINNESS WORLD RECORDS™ title for the ‘Highest Altitude Multirotor/Drone Fireworks Display’ was the tower of fireworks 1,055.8 metres high, taller than any skyscraper in the world. The second GUINNESS WORLD RECORDS™ title was for the ‘Most Remote Operated Multirotors/Drones Launching Fireworks Simultaneously’, when 452 drones launched fireworks simultaneously to create the ‘Happy New Year’ visual in the sky.
The celebration was organised by following all social distancing protocols and other safety guidelines with the support of the National Authority for Emergency, Crisis & Disaster Management and the Ministry of Health & Prevention. Visitors watched the festivities from special Viewing Decks along Al Marjan Island and Al Hamra Village. Video link here
*Source: AETOSWire
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20211231005082/en/
Contact information
Nivine William
ASDA’A BCW | +97144507600
nivine.william@bcw-global.com
www.asdaa-bcw.com | www.arabyouthsurvey.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom